Discrete roles for peroxisome proliferator-activated receptor γ and retinoid X receptor in recruiting nuclear receptor coactivators

Molecular and Cellular Biology

Volumn 20, Issue 21, 2000, Pages 8008-8017

  Yang, W ^a   Rachez, C ^a   Freedman, L P ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS RECEPTOR; LIGAND; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATOR RECEPTOR GAMMA; PROTEIN KINASE; PROTEIN KINASE P160; PROTEIN P160; RECEPTOR PROTEIN; RETINOID X RECEPTOR; UNCLASSIFIED DRUG; VITAMIN D RECEPTOR; VITAMIN D3 RECEPTOR INTERACTING PROTEIN;

ALLOSTERISM; ANIMAL CELL; ARTICLE; BINDING AFFINITY; GENE ACTIVATION; HUMAN; HUMAN CELL; LIGAND BINDING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RECEPTOR BINDING; TRANSACTIVATION;

3T3 CELLS; ANIMAL; CARRIER PROTEINS; CELL LINE; CELL NUCLEUS; DIMERIZATION; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUTATHIONE TRANSFERASE; LIGANDS; MICE; MODELS, BIOLOGICAL; PROTEIN BINDING; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, RETINOIC ACID; RECOMBINANT FUSION PROTEINS; SUPPORT, U.S. GOV'T, P.H.S.; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS; TRANSFECTION;

EID: 0033777133     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.20.21.8008-8017.2000     Document Type: Article

References (55)

1. Thiazolidinediones produce a conformational change in peroxisomal proliferator-activated receptor-gamma: Binding and activation correlate with antidiabetic actions in db/db mice
2. Activation of PPARγ leads Co inhibition of anchorage-independent growth of human colorectal cancer cells
3. A novel N-aryl tyrosine activator of peroxisome proliferator-activated receptor-gamma reverses the diabetic phenotype of the Zucker diabetic fatty rat
4. Functional interactions between the estrogen receptor and DRIP205, a subunit of the heteromeric DRIP coactivator complex
5. The enhanceosome and transcriptional synergy
6. Regulation of hormone-induced histone hyperacetylation and gene activation via acetylation of an acetylase
7. Binding of liganded vitamin D receptor to the vitamin D receptor interacting protein coactivator complex induces interaction with RNA polymerase II holoenzyme
8. N-(2-Benzoylphenyl)-L-tyrosine PPARγ agonists. 3. Structure-activity relationship and optimization of the N-aryl substituent
9. N-(2-Benzoyl-phenyl)-L-tyrosine PPAR-γ agonists. 2. Structure-activity relationship and optimization of the phenyl alkyl ether moiety
10. Induction of solid tumor differentiation by the peroxisome proliferator-activated receptor-gamma ligand troglitazone in patients with liposarcoma
11. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei
12. Peroxisome proliferator-activated receptors and retinoic acid receptors differentially control the interactions of retinoid X receptor heterodimers with ligands, coactivators, and corepressors
13. Control of the peroxisomal beta-oxidation pathway by a novel family of nuclear hormone receptors
14. Ligands for peroxisome proliferator-activated receptor gamma and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice
15. Ligand induction of a transcriptionally active thyroid hormone receptor coactivator complex
16. 15-Deoxy-delta12,14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma
17. Increasing the complexity of coactivation in nuclear receptor signaling
18. Asymmetry in the PPAR-gamma/RXR-alpha structure reveals the molecular basis of heterodimerization among nuclear receptors
19. Interaction of the peroxisome-proliferator-activated receptor and retinoid X receptor
20. The coregulator exchange in transcriptional functions of nuclear receptors
21. A novel human SRB/MED-containing cofactor complex, SMCC, involved in transcription regulation
22. N-(2-Benzoylphenyl)-L-tyrosine PPARγ agonists. 1. Discovery of a novel series of potent antihyperglycemic and antihyperlipidemic agents
23. Interleukin-4-dependent production of PPAR-gamma ligands in macrophages by 12/15-lipoxygenase
24. Evidence for a common mechanism of action for fatty acids and thiazolidinedione antidiabetic agents on gene expression in preadipose cells
25. A one-vial method for routine extraction and quantification of free fatty acids in blood and tissue by HPLC
26. Fatty acids and retinoids control lipid metabolism through activation of peroxisome proliferator-activated receptor-retinoid X receptor heterodimers
27. Enhancement of adipocyte differentiation by an insulin-sensitizing agent
28. A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation
29. Convergence of 9-cis-retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors
30. 9-cis-retinoic acid signaling: Changing partners causes some excitement
31. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma)
32. Retinoid X receptor-vitamin D3 receptor heterodimers promote stable preinitiation complex formation and direct 1,25-dihydroxyvitamin D3-dependent cell-free transcription
33. Nuclear receptor cofactors as chromatin remodelers
34. Regulating adipogenesis
35. Terminal differentiation of human breast cancer through PPAR gamma
36. Sensitization of diabetic and obese mice to insulin by retinoid X receptor agonists
37. Composite co-activator ARC mediates chromatin-directed transcriptional activation
38. Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-gamma
39. Novel sequence determinants in peroxisome proliferator signaling
40. The DRIP complex and SRC-1/p160 coactivators share similar nuclear receptor binding determinants but constitute functionally distinct complexes
41. Ligand-dependent transcription activation by nuclear receptors requires the DRIP complex
42. A novel protein complex that interacts with the vitamin D3 receptor in a ligand-dependent manner and enhances VDR transactivation in a cell-free system
43. Transactivation by retinoid X receptor-peroxisome proliferator-activated receptor gamma (PPARγ) heterodimers: Intermolecular synergy requires only the PPARγ hormone-dependent activation function
44. Interdomain communication regulating ligand binding by PPAR-gamma
45. Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor
46. Terminal differentiation of human liposarcoma cells induced by ligands for peroxisome proliferator-activated receptor gamma and the retinoid X receptor
47. Competition between thyroid hormone receptor-associated protein (TRAP) 220 and transcriptional intermediary factor (TIF) 2 for binding to nuclear receptors. Implications for the recruitment of TRAP and p160 coactivator complexes
48. The mouse peroxisome proliferator activated receptor recognizes a response element in the 5' flanking sequence of the rat acyl CoA oxidase gene
49. Identification of a peroxisome proliferator-responsive element upstream of the human peroxisomal fatty acyl coenzyme A oxidase gene
50. Ligand-independent activation domain in the N terminus of peroxisome proliferator-activated receptor gamma (PPARγ). Differential activity of PPARγ1 and -2 isoforms and influence of insulin
51. The PPARs: From orphan receptors to drug discovery
52. The structure-activity relationship between peroxisome proliferator-activated receptor gamma agonism and the antihyperglycemic activity of thiazolidinediones
53. Differential activation of peroxisome proliferator-activated receptors by eicosanoids
54. The TRAP220 component of a thyroid hormone receptor-associated protein (TRAP) coactivator complex interacts directly with nuclear receptors in a ligand-dependent fashion
55. Isolation and characterization of PBP, a protein that interacts with peroxisome proliferator-activated receptor